The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs.
about
Quinine, an old anti-malarial drug in a modern world: role in the treatment of malariaGenetic diversity of Plasmodium falciparum isolates from uncomplicated malaria cases in Ghana over a decadeHigh-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool.Community perceptions of malaria and malaria treatment behaviour in a rural district of Ghana: implications for artemisinin combination therapy.Limited ability of Plasmodium falciparum pfcrt, pfmdr1, and pfnhe1 polymorphisms to predict quinine in vitro sensitivity or clinical effectiveness in UgandaEfficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children.The outcome of a test-treat package versus routine outpatient care for Ghanaian children with fever: a pragmatic randomized control trialSelective sweeps and genetic lineages of Plasmodium falciparum drug -resistant alleles in Ghana.Estimating malaria parasite density: assumed white blood cell count of 10,000/μl of blood is appropriate measure in Central Ghana.Surveillance of molecular markers of Plasmodium falciparum resistance to sulphadoxine-pyrimethamine 5 years after the change of malaria treatment policy in Ghana.Assessment of the Worldwide Antimalarial Resistance Network Standardized Procedure for In Vitro Malaria Drug Sensitivity Testing Using SYBR Green Assay for Field Samples with Various Initial Parasitemia Levels.Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial.Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy.A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs.Selection of parasites with diminished drug susceptibility by amodiaquine-containing antimalarial regimens in Uganda.Efficacy of Artesunate/Amodiaquine in the Treatment of Uncomplicated Malaria among Children in Ghana.In vitro activities of quinine and other antimalarials and pfnhe polymorphisms in Plasmodium isolates from Kenya
P2860
Q17485067-6C06C709-09AD-4FD9-9510-BCEDB5428A43Q26700160-53E99F80-8BA8-49F0-B23B-8A9DC5CDE997Q30619647-8FD7EAB0-D8EA-44A5-A5F1-130F01B74A1EQ33630844-F7D0AD6E-66F2-4C8A-9DE2-ECC386679CDCQ34529355-4762B013-45AD-4C4C-AB60-91C39347055AQ34562333-3595F34C-D9D8-4550-A77F-1D6F22C76F71Q34651041-1F695865-68C9-4F00-8E98-880C4352404DQ34763548-0B80C724-E90D-4D7B-A693-A5216331BA86Q36138954-9A873334-5907-4863-9ADF-F9DB4653FCA0Q36450234-35DC3190-F5CE-4E2C-8867-E29B3D6D8155Q36729948-46D57C85-BCC1-46FD-B5BB-A246AD57217CQ37272095-3C2F4D78-3A49-4BCD-953D-7E188EBCF6FFQ37285721-8BBDB195-2106-42EE-A9B1-16900E075FFCQ37426615-2CF2CA87-8680-4EA1-8E0B-063F721BC1F8Q37436582-102DF2AE-3E45-48A9-8E13-1F308D5D742CQ38657672-B53EA3BF-E2B2-4EA2-870E-99E826094602Q41935745-35F9D3B3-56CD-403E-975F-11E6FE5BD802
P2860
The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs.
@en
type
label
The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs.
@en
prefLabel
The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs.
@en
P2093
P2860
P356
P1476
The in-vitro susceptibilities of Ghanaian Plasmodium falciparum to antimalarial drugs.
@en
P2093
P2860
P304
P356
10.1179/136485907X176553
P577
2007-07-01T00:00:00Z